Search results

16 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Diabetes drug lowers risk of cardiovascular complications, kidney disease
For the first time, a large clinical trial showed across-the-board cardiovascular benefit of a diabetes drug – liraglutide – a much-needed outcome for people with type 2 diabetes.
Located in News / 2016 / June
UNC clinical trials play crucial role in FDA approval for diabetes drug
Led by John Buse, MD, PhD, director of the UNC Diabetes Care Center, the clinical research of UNC doctors and the participation of thousands of patients culminates in a new, effective, and safe daily injectable drug to combat type-2 diabetes.
Located in News / 2016 / November
Buse leads clinical trial of new type 1 diabetes treatment
The study is designed to evaluate whether TTP399 is well tolerated when administered as an add-on to insulin therapy and can improve daily glucose profiles and HbA1c in people living with type 1 diabetes.
Located in News / 2017 / November
Scientists create painless patch of insulin-producing beta cells to control diabetes
The new “smart cell patch” developed at UNC and NC State is a proof of principle to treat millions of people with type-1 and advanced type-2 diabetes.
Located in News / 2016 / March
NC TraCS and partners awarded $58.1 million to accelerate research discoveries
The NIH award features a new partnership with NC State, while the UNC-Chapel Hill-led Clinical and Translational Science Award Program continues its alliance with RTI International and N.C. A&T State University.
Located in News / 2018 / April
UNC scientist’s drive for a cancer cure inspired by the father he doesn’t remember
Zhen Gu, a biomedical engineer at the University of North Carolina and N.C. State University, is featured in STAT News for his work on cancer.
Located in News / 2016 / August
UNC precision medicine symposium, workshop set for October 31
Sponsored by the UNC School of Medicine Office of Research and NC TraCS, the sessions will focus on leveraging the strengths of UNC researchers and UNC Health Care to develop research related to precision medicine.
Located in News / 2017 / September
UNC research, diabetes expertise featured in video at international conference
The American Diabetes Association featured UNC-Chapel Hill diabetes experts and leaders in a video presented at the ADA's 78th Scientific Sessions this summer.
Located in News / 2018 / July
Liquid Metal ‘Nano-Terminators’ Target Cancer Cells
The new cancer drug delivery system improved efficacy of standard chemotherapy for ovarian cancer in mice with limited toxicity.
Located in News / 2015 / December
Life-extending benefits of liver cancer drug not realistic for many patients
The drug sorafenib can have serious side effects and significant out-of-pocket costs for advanced liver cancer patients, according to a study led by UNC’s Hanna Sanoff, MD, MPH.
Located in News / 2016 / May